CLINICAL_TRIALS
trial_result
· 2014-08-28
Clinical Trial Update: Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer [Phase 2]
Summary
A Phase 2 trial evaluating a genomic predictor of platinum resistance to guide therapy in stage IIIB/IV non-small cell lung cancer was terminated; results were …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Duke University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-28